Loading...
| No images? Click here Friday 07.29.22 | Issue 166 Subscribe to receive this weekly updateWHO / Mihail Grigorev Coronavirus disease (COVID-19) updates A virtual press briefing with simultaneous translation in all UN languages with the participation of the WHO Director-General is expected for next week. However, we will update if this changes. Media advisories with Zoom links/dial-in details will be emailed in advance. 29 July-2 August WHO at the 24th International AIDS Conference (AIDS2022) The theme of AIDS2022 is “Re-engage and follow the science,” with more than 600 sessions including 70 satellite sessions. Happening in Montreal, Canada, the conference provides a unique opportunity for WHO to promote its policies, guidelines and tools and to demonstrate its contribution to the health sector response to HIV and related areas of health. More information on AIDS2022 programme. More information on WHO at AIDS2022. Media are invited to register here. Monday, 1 August WHO HQ closed Please note WHO Headquarters in Geneva, Switzerland, will be closed next Monday, 1 August, for a holiday observance. This may delay our response to media queries. WHO HQ will reopen Tuesday, 2 August. 1-6 August WHO will be taking part at the 7th World Congress on Leishmaniasis (WorldLeish7) - a scientific meeting on leishmaniasis happening next week, 1-6 August in Cartagena, Colombia. WorldLeish7 will highlight the advances and new research findings in this area. More than 1500 researchers, professionals and students will come together to identify and generate new ideas, promote a multidisciplinary approach to research and strengthen collaboration among technological development groups and research centers around the world. The WHO Road Map on NTDs 2021-2030 includes visceral leishmaniasis among the diseases targeted for elimination as a public health problem and cutaneous leishmaniasis among those targeted for control. WHO recently published a set of guidelines dedicated to new treatment recommendations for visceral leishmaniasis in patients who are coinfected with the human immunodeficiency virus (HIV). The guideline targets visceral leishmaniasis in East Africa and South-East Asia. More on WorldLeish7. Sign up for our newsletters here. Check out the WHO series, Science in 5. See more upcoming WHO events here. Latest WHO Disease Outbreak News (DONs) here. Listen to Global Health Matters. Access WHO photos available for media use here. WHO Media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list.
|
Loading...
Loading...
